ArticleBMC urology2026

Neoadjuvant immunotherapy combined with HER2-targeted antibody-drug conjugate in bladder urothelial carcinoma: a case report.

Zhengmin Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.